ArticleBiomacromolecules2025
All-Cellulose Hydrogel-Based Bioinks for the Versatile 3D Bioprinting of Different Cell Lines.
Article in Biomacromolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Support-Enabled 3D Printing of Complex Anisotropic Hydrogel Structures Using Cellulose-Based Inks: Pathways Toward Biomimetic Human Aorta Models.ACS biomaterials science & engineering · 2026Article
- Decoupling Mechanical and Conductive Properties of Cellulose Ionogels for Flexible Electronics: A Review.Gels (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The development of bioink formulations with suitable properties is fundamental for the progress of 3D bioprinting. The potential of cellulose, the most abundant biopolymer, in this realm has often been underestimated, relegating it essentially to a reinforcement additive of bioinks. In this work, cell-laden bioink formulations, composed exclusively of cellulose, viz., "all-cellulose bioinks", were developed by combining carboxymethyl cellulose (CMC) and nanofibrillated cellulose (NFC) in different mass proportions (90/10, 80/20, and 70/30%). The incorporation of NFC increases the printability of the inks (from Pr = 0.7 to 0.9) while maintaining their shear-thinning behavior, and increasing contents of NFC also decrease the degradation rate of the hydrogels after 7 days. The bioprinting of the cell-laden formulations, with HaCaT (keratinocyte) and ATDC5 (chondrogenic) cells, resulted in high (>80%) cell viabilities for up to 7 days, corroborating the versatility of the bioinks and their potential to originate distinct 3D living structures for biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.